Brainomix

Medical Technologies & Devices

Email: [email protected]
Phone: 01865 582730
Website: https://www.brainomix.com/
Membership category: Corporate (41-60)

Seacourt Tower, Botley, Oxford, OX2 0JJ, United Kingdom

About Brainomix

Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in stroke, lung fibrosis, and cancer. With origins as a spin-out from the University of Oxford, Brainomix is an expanding commercial-stage company that has innovated award-winning imaging biomarkers and software solutions that are used in more than 30 countries worldwide. Its first product, the e-Stroke platform, provides clinicians with the most comprehensive stroke imaging solution, driving faster treatment times and improving functional independence for patients.

Therapeutic area(s)

Medical Devices
Neurology
Platform Technology
Respiratory System
Oncology
Digital Health
Translational Medicine
Biomarkers

Articles Brainomix has contributed to

25 Jul 2024

New studies validate the value of Brainomix AI technology across US stroke networks

The studies presented this week at the Society of Neurointerventional Surgery (SNIS) underline the company’s rigorous evidence-based approach to developing and validating novel AI solutions that can help to optimize patient care across stroke networks.

Member news

19 Jul 2024

Brainomix and Boehringer Ingelheim launch strategic partnership in fibrosing lung disease

The project will evaluate the real-world impact of Brainomix’s e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US.